Halozyme Therapeutics
HALO
#2478
Rank
S$7.79 B
Marketcap
$61.29
Share price
-15.40%
Change (1 day)
15.13%
Change (1 year)

Halozyme Therapeutics (HALO) - Net assets

Net assets on the balance sheet as of September 2024 : S$0.60 Billion

According to Halozyme Therapeutics's latest financial reports the company has S$0.60 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$0.11 B-51.38%
2022-12-31$S$0.22 B-14.51%
2021-12-31$S$0.26 B33.25%
2020-12-31$S$0.19 B61.52%
2019-12-31$S$0.12 B-63.61%
2018-12-31$S$0.34 B22.01%
2017-12-31$S$0.27 B-692.83%
2016-12-31$-S$47.01 Million-177.29%
2015-12-31$S$60.82 M11.32%
2014-12-31$S$54.64 M-315.74%
2013-12-31$-S$25.33 Million-142.39%
2012-12-31$S$59.74 M323.22%
2011-12-31$S$14.11 M-46.15%
2010-12-31$S$26.21 M170.49%
2009-12-31$S$9.69 M-55.94%
2008-12-31$S$21.99 M-73.54%
2007-12-31$S$83.12 M134.87%
2006-12-31$S$35.39 M16.75%
2005-12-31$S$30.31 M25.35%
2004-12-31$S$24.18 M3707.96%
2003-12-31$S$0.63 M-196.43%
2002-12-31$-S$0.66 Million-1657.78%
2001-12-31$S$0.04 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-S$0.31 Billion-149.87%๐Ÿ‡บ๐Ÿ‡ธ USA
S$19.22 B 3,063.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.34 B 1,602.66%๐Ÿ‡บ๐Ÿ‡ธ USA
S$124.26 B 20,345.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$105.06 B 17,185.42%๐Ÿ‡ซ๐Ÿ‡ท France
S$94.19 B 15,397.58%๐Ÿ‡บ๐Ÿ‡ธ USA